ASTELLAS PHARMA INC.
Patent Owner
Stats
- 290 US PATENTS IN FORCE
- 17 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 290 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 10,729 Total Citation Count
- Oct 20, 1983 Earliest Filing
- 601 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0360,779 PHARMACEUTICAL COMPOSITION COMPRISING BICYCLIC NITROGEN-CONTAINING AROMATIC HETEROCYCLIC AMIDE COMPOUND AS ACTIVE INGREDIENTDec 08, 15Dec 21, 17[A61K, C07D]
2017/0360,780 PHARMACEUTICAL COMPOSITION COMPRISING BICYCLIC NITROGEN-CONTAINING AROMATIC HETEROCYCLIC AMIDE COMPOUND AS ACTIVE INGREDIENTDec 08, 15Dec 21, 17[A61K]
2017/0360,781 PHARMACEUTICAL COMPOSITION COMPRISING BICYCLIC NITROGEN-CONTAINING AROMATIC HETEROCYCLIC AMIDE COMPOUND AS ACTIVE INGREDIENTDec 08, 15Dec 21, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9776004 Method for treating premature ejaculation and method for controlling premature ejaculation treatment deviceJul 13, 15Oct 03, 17[A61N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0196,859 PHARMACEUTICAL COMPOSITION COMPRISING PYRAZINE CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENTAbandonedMay 27, 15Jul 13, 17[A61K]
2016/0346,255 METHODS, AGENTS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY CONDITIONSAbandonedAug 12, 16Dec 01, 16[A61K, G01N]
2016/0199,371 PHARMACEUTICAL COMPOSITION HAVING PYRIMIDINE COMPOUND AS ACTIVE INGREDIENTAbandonedAug 27, 14Jul 14, 16[A61K]
2016/0192,626 Method For Creating Endometriotic Cells And Endometriosis Model AnimalAbandonedAug 27, 14Jul 07, 16[C12N, A01K]
2015/0368,220 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING STRESS URINARY INCONTINENCE OR MIXED URINARY INCONTINENCE, AND METHOD FOR SCREENING COMPOUND COMPRISED IN SAID PHARMACEUTICAL COMPOSITIONAbandonedJul 09, 13Dec 24, 15[C07D, C07C, G01N]
2015/0190,416 FILAGGRIN PRODUCTION PROMOTER, THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH REDUCTION IN PRODUCTION OF FILAGGRIN, AND METHOD FOR SCREENING FOR SAID THERAPEUTIC AGENTAbandonedJul 12, 13Jul 09, 15[A61K, C12Q]
2015/0031,734 PHARMACEUTICAL COMPOSITION CONTAINING MIRABEGRONAbandonedMar 29, 13Jan 29, 15[A61K, C07D, C07C]
2014/0066,385 METHOD FOR TREATING CANCER BY COMBINED USE OF DRUGSAbandonedSep 09, 13Mar 06, 14[A61K]
8629126 Quinolone derivative or pharmaceutically acceptable salt thereofExpiredFeb 02, 12Jan 14, 14[A61K]
2013/0338,358 METHOD FOR PRODUCING DI(ARYLAMINO)ARYL COMPOUND AND SYNTHETIC INTERMEDIATE THEREFORAbandonedJan 27, 12Dec 19, 13[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.